Roche
Illumina reportedly agrees to Roche's $8.2-bn takeover offer
21 Dec 2012
The potential acquisition of Illumina would make Roche a market leader in gene sequencing, a procedure that helps develop personalised drugs to suit individual patients
Roche’s patent on Hepatitis C drug set aside
02 Nov 2012
The amended Patents Act allows any interested party, including patients, to challenge a patent after it was granted
Roche ends $6.7-bn hostile bid for Illumina
19 Apr 2012
The potential acquisition of Illumina would have made Roche a market leader in gene sequencing, a procedure that helps develop targeted therapies
.webp)
